Dok Hyun Yoon, Hyungwoo Cho, Jaewon Hyung, Yoon Seok Choi, Youngwoo Jeon, Seok Jin Kim, Youngil Koh, Nari Yun, Woohyung Lee, Chanmi Kim, Myoung Ho Jang. "Trial in progress: A Phase 2a Study of GI-102 (CD80/IL2v3) as a consolidation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma following anti-CD19 chimeric antigen receptor T-cell therapy (CARNATION trial)." Blood, 2025. doi:10.1182/blood-2025-2399